Document is current
Any future updates will be listed below
-
Authors
Graell, Marta
Bosch, Rosa https://orcid.org/0000-0002-7596-183X
Soler Artigas, María https://orcid.org/0000-0002-3213-1107
Alemany, Silvia https://orcid.org/0000-0002-7925-6767
Llonga, Natalia https://orcid.org/0000-0003-4325-6201
Carabí-Gassol, Pau https://orcid.org/0000-0001-9105-2946
Zubizarreta-Arruti, Uxue https://orcid.org/0009-0005-2267-6196
Macias-Chimborazo, Valeria
Mitjans, Marina https://orcid.org/0000-0001-5543-7320
Pagerols, Mireia
Pagespetit, Èlia
Prat, Raquel
Puigbó, Júlia
Rivas, Cristina
Martinez, Laura
Ramos-Quiroga, Josep Antoni https://orcid.org/0000-0003-1622-0350
Casas, Miquel https://orcid.org/0000-0003-3496-8522
Ribasés, Marta https://orcid.org/0000-0003-1039-1116
Cabana-Domínguez, Judit https://orcid.org/0000-0002-4732-7284
- License Information
-
More Information
Article History
Received: 24 July 2025
Revised: 16 April 2026
Accepted: 13 May 2026
First Online: 22 May 2026
Competing interests
: J.A.R.Q was on the speakers’ bureau and/or acted as consultant for Biogen, Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogi, Sincrolab, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Takeda, Shionogi, Bial and Medice. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Janssen- Cilag, Shire, Oryzon, Roche, Psious, and Rubió. The rest of authors have nothing to disclose.
: The project was approved by the Ethics Committee at the Hospital Universitari Vall d’Hebron (PR(AG)491/2022) and the CEIm Fundació Sant Joan de Déu (PIC-154-22), methods were performed in accordance with the relevant guidelines and regulations and written informed consent was obtained from parents or caregivers.
